A federal jury in Seattle returned a $152,093 verdict for Valve and against inventor Leigh Rothschild and his patent-licensing entities — finding violations of the Washington Patent Troll Prevention Act, the Washington Consumer Protection Act, and a 2016 patent licensing settlement. It is, according
An Eastern District of New York judge denied Bemmo’s motion to dismiss Ridge Wallet’s patent infringement and trade dress claims, holding that claim construction disputes are premature at the pleading stage and that Ridge Wallet adequately alleged secondary meaning and non-functionality
In a same-day companion ruling to Meril v. Edwards, the UPC Court of Appeal articulated a comprehensive inventive-step framework: identify the objective problem from the perspective of the skilled person, choose a realistic starting point in the prior art, and assess whether the skilled person ̵
Same-day companion to Amgen v. Sanofi/Regeneron, the UPC Court of Appeal in Meril v. Edwards held that the ‘same parties’ test under Art. 33(4) UPCA looks to identity of interests; that disclosed embodiments are generally covered by the patent claims unless the specification clearly teac
The UPC Court of Appeal set out a workable test for when a generic pharmaceutical’s pre-launch activity creates an imminent threat of infringement supporting provisional measures: a bare marketing authorisation does not, but completion of national health-technology-assessment, pricing, and rei
The Japan Intellectual Property High Court reversed the Tokyo District Court and held that a generic narlfrafen hydrochloride (nalfurafine) anti-itch product infringes Toray’s term-extended pharmaceutical use patent on Remitch, awarding the patentee approximately ¥21.7 billion (~US$140 million
Korea’s Supreme Court affirmed dismissal of indirect patent-infringement claims against a domestic manufacturer that produced 13 individual conjugate substrates in Korea but exported them for final mixing into a 13-valent pneumococcal vaccine abroad, holding that under the territoriality princ
The UPC Düsseldorf Local Division articulated the substantive framework for second medical-use claim infringement: the alleged infringer must offer or place the medicinal product on the market in a way that leads or may lead to the claimed therapeutic use, with knowledge or constructive knowledge th
The Supreme People’s Court IP Tribunal reversed a first-instance finding of patent infringement in a power-management chip dispute, holding that pulse-signal generation circuit features in the accused chip differed from the patented features in means, function, and effect — and therefore neith
The CJEU Grand Chamber held that Article 4(1) of Regulation 1215/2012 entitles a court of a defendant’s domicile member state to hear infringement claims regarding a European patent’s national parts validated in other member states (and even in non-EU states), notwithstanding invalidity